A characteristic morning silhouette under a quilt, an academic paper describing “teapot effect”, a blue diamond-shaped pill in a glass. The phenomenon that everyday language consigns to slang and euphemism appears, in anatomy, physiology, pharmacology, and cultural-history, in markedly different faces from each discipline’s perspective.

Bokki (Japanese: 勃起, bokki; Latin: erectio penis; English: erection, penile erection, tumescence) is the Japanese term for the physiological state of penile rigidity, produced through corpus-cavernosum blood-engorgement and corresponding venous-outflow restriction. The category sits in the male-anatomy-and-sexual-function vocabulary at a position covered by the Japanese Society for Sexual Medicine clinical guidelines under the definition “the neurovascular event centred on corpus-cavernosum smooth-muscle relaxation”.

Overview

Erection is a phenomenon widely observed in mammalian male anatomy, with multiple types of trigger in humans including sexual excitement, sleep-cycle phases, and physical stimulation. The transition from the flaccid state to full rigidity normally takes 5-15 seconds to tens of seconds. At full rigidity, corpus-cavernosum internal pressure approaches systemic blood pressure (around 100 mmHg), and the tunica albuginea (the dense connective-tissue envelope of the corpora) reaches its extension-limit, producing maximum rigidity.

The contemporary physiological understanding of erection developed through 19th-and-20th-century histological and haemodynamic research, the 1970s-onward advances in corpus-cavernosum physiology, the 1980s elucidation of the nitric-oxide signalling pathway, and the 1998 introduction of sildenafil and the resulting clinical-pharmacology developments. Erection is not a stand-alone phenomenon but a structural-element interacting with erectile dysfunction, partial-loss-of-erection (nakaore), nocturnal penile tumescence (NPT), and priapism, with these categories together constituting the core of sexual-medicine.

Distinction in vocabulary

The English vocabulary uses erection in essentially-clinical-and-everyday register, tumescence in clinical-and-medical register (particularly with reference to nocturnal penile tumescence), and a substantial range of casual-and-slang terms in vernacular register. The Japanese vocabulary uses bokki (勃起) in a register that maps closer to the clinical-and-medical English erection, with the parallel use of vernacular terms (tatsu, gin-gin, etc.) for casual register.

The Japanese term thus operates with a slightly more medical-coded register than the everyday English erection. The medical-and-legal Japanese register treats bokki as the formal-and-medical-standard term, with the vernacular vocabulary distinguished as a separate register. In English, the same erection term operates across both clinical and casual contexts.

Etymology

The compound 勃起 (bokki) is a Sino-Japanese medical-language term built from 勃 (botsu, “to arise suddenly”) and 起 (ki, “to rise”). The compound has a long classical-Chinese background in non-erotic-register meaning (“sudden arousal / rising”), e.g. botsu-zen to shite tatsu (“to rise suddenly”). The medical-specific application stabilised in Meiji-period Japanese medical translation, where the compound was selected as the standard rendering of Latin erectio and English erection.

English erection derives from Latin erigere (“to raise / set up”), entering English from the 14th century onward. Tumescence derives from Latin tumescere (“to swell”), with the meaning emphasising the volume-increase aspect of the phenomenon and operating principally in clinical contexts (particularly with reference to nocturnal-penile-tumescence monitoring).

Anatomical substrate

The physiological stage of erection is the structural array of the penis: the bilateral corpora cavernosa penis (the principal erectile bodies) and the central corpus spongiosum penis (surrounding the urethra). The corpora cavernosa are dorsally-positioned, enclosed in the strong tunica albuginea, and contain numerous cavernous spaces (blood-vascular spaces) within their parenchyma. Blood-supply enters via the helicine arteries (arteriae helicinae) and is surrounded by trabecular smooth muscle.

In the flaccid state, the cavernous-space smooth-muscle maintains contraction, restricting blood-inflow to the cavernous spaces. With sexual-excitement or reflex-stimulation, smooth-muscle relaxation produces sudden blood-inflow increase, with cavernous-space expansion. The expanded cavernous tissue mechanically compresses the subtunical venous plexus, restricting venous outflow. The combined “arterial inflow increase + venous outflow restriction” mechanism produces corpus-cavernosum internal pressure increase to near-systemic-arterial pressure.

The glans and corpus spongiosum do not reach the same internal pressure as the corpora cavernosa, retaining a softer-elastic state during erection. The differential is functionally important: it prevents the urethra from being mechanically compressed beyond passage-capacity during ejaculation.

Physiological mechanism

Nitric oxide / cGMP pathway

The molecular core of erection is the nitric oxide (NO) signalling pathway. Sexual stimulation triggers parasympathetic-nerve descending input from the sacral erection centre and non-adrenergic non-cholinergic (NANC) nerve-terminal NO release through neuronal NO synthase (nNOS). Corpus-cavernosum vascular endothelial cells also produce NO through endothelial NO synthase (eNOS).

Released NO diffuses into corpus-cavernosum smooth-muscle cells and activates soluble guanylate cyclase (sGC). sGC produces cyclic GMP (cGMP) from GTP. Elevated intracellular cGMP activates protein kinase G (PKG), which reduces intracellular calcium and produces smooth-muscle relaxation. The Ignarro-and-Furchgott-led NO research (recognised in the 1998 Nobel Prize for Physiology or Medicine) provided the molecular substrate for this pathway, with the penile-specific application following.

cGMP is degraded by phosphodiesterase type 5 (PDE5) to 5’-GMP. PDE5 activity sets the steady-state intracellular cGMP concentration, and PDE5-inhibitor drugs (discussed below) work by inhibiting cGMP degradation and thus sustaining the relaxation-and-erection state.

Neural control

Erection’s neural control involves three autonomic-and-somatic-nerve systems acting in coordination. Parasympathetic input from the sacral spinal cord (S2-S4) erection centre travels via the pelvic splanchnic and cavernous nerves to corpus-cavernosum tissue, producing erection-initiation-and-maintenance. Sympathetic input from the lumbar spinal cord (L1-L2) travels via the hypogastric nerve to penile tissue, mediating smooth-muscle contraction (flaccid-state maintenance) and post-ejaculation detumescence.

Somatic-nerve input from the dorsal penile nerve (a branch of the pudendal nerve) transmits glans-and-shaft-skin sensation to the spinal cord, providing the sensory-input pathway for reflex erection. Central-nervous-system regions including the medial preoptic area (MPOA), paraventricular nucleus (PVN) of the hypothalamus, and brainstem tegmental nuclei provide upper-level control as demonstrated in animal experiments.

Endocrine control

Testosterone and broader androgen signalling provide the endocrine substrate for erectile function. Testosterone maintains NOS expression in corpus-cavernosum smooth-muscle cells, regulates PDE5 activity, and influences nocturnal-penile-tumescence frequency and rigidity. Age-related testosterone decline (late-onset hypogonadism / LOH syndrome, see male menopause) is a recognised endocrine background for ED in clinical practice.

Prolactin elevation, thyroid dysfunction, and adrenocortical disorders may also affect erectile function and are included in standard endocrine-screening workups for sexual-function-disorder cases.

Types of erection

Erection is conventionally classified by triggering input into three categories.

Psychogenic erection

Psychogenic erection is the erection produced by central-stimulation inputs — visual, auditory, imaginative, or memory-based stimulation. The pathway involves cerebral-cortical and limbic-system processing, with descending control through the hypothalamus and brainstem to the sacral erection centre. Spinal-cord-injury patients show distinct preservation-and-loss patterns of psychogenic versus reflex erection depending on the injury level, providing neurological localisation-information.

Reflex erection

Reflex erection is the erection produced by physical stimulation of the penile or perineal region, mediated by the sacral spinal-cord local-reflex arc. The pathway does not require central-nervous-system involvement and is preserved in some upper-spinal-cord-injury cases. In everyday non-sexual contexts, reflex erection can be elicited by clothing friction, walking, cycling, and similar non-sexual physical stimulation.

Nocturnal penile tumescence (NPT)

Nocturnal penile tumescence is the involuntary periodic erection that accompanies REM-sleep cycles. Healthy adult males record approximately 3-5 erection-episodes per night, with a total erection-time of 90-180 minutes. Karacan’s 1978 sleep-physiology research established the detailed picture. NPT has clinical-diagnostic importance in distinguishing psychogenic ED (NPT preserved) from organic ED (NPT reduced), with NPT monitoring (Rigiscan method) as the standard diagnostic adjunct.

Morning erection is the residual NPT from the immediately-pre-waking REM phase, persisting into the wake state. It is not necessarily a marker of sexual desire or urinary urgency. NPT may have a physiological role in maintaining corpus-cavernosum tissue oxygenation, with implications for the long-term maintenance of erectile function.

Pathology

Erectile dysfunction (ED)

Erectile dysfunction (ED, bokki shōgai, in’i) is defined as “the inability to achieve or maintain an erection sufficient for satisfactory sexual activity” (Japanese ED Practice Guidelines, 3rd edition). The condition is classified by clinical pattern into “initiation difficulty” (erection cannot be achieved) and “maintenance difficulty” (erection achieved but not sustained, the partial-loss-of-erection (nakaore) pattern).

ED aetiologies divide into: (1) vascular (atherosclerosis, hypertension, diabetes, dyslipidaemia, smoking); (2) neurological (spinal-cord injury, post-pelvic-surgery state, peripheral neuropathy); (3) endocrine (LOH syndrome, thyroid dysfunction); (4) drug-related (antihypertensives, antidepressants, antipsychotics); and (5) psychogenic (performance anxiety, relationship conflict, depression). In clinical practice, mixed aetiologies are the typical presentation.

Priapism

Priapism is sustained-erection persisting beyond the cessation of sexual stimulation. Erection-duration exceeding 4 hours is treated as a urological emergency. The ischaemic (low-flow) form carries tissue-necrosis risk through corpus-cavernosum blood stasis and, untreated, can lead to permanent ED. Treatment involves corpus-cavernosum aspiration, pharmacological reversal, or surgical intervention. Underlying causes include sickle-cell disease, haematological malignancy, and intracavernosal-injection-therapy reactions.

Age-related changes

Age-related changes in erectile function include: (1) slowed initiation; (2) reduced maximum rigidity; (3) shortened maintenance duration; (4) reduced NPT frequency; and (5) extended post-ejaculatory refractory period. The combination reflects atherosclerotic progression in penile vasculature, age-related testosterone decline, and reduced nerve-transmission efficiency.

The boundary between age-related-change and treatable-pathology is contextual. Subjective satisfaction with sexual life serves as the clinical-judgement baseline. Qualitative erectile-function change is essentially universal in men aged 50 and above; whether the changes are framed as “pathological and treatable” or “natural and accepted” depends on individual values and cultural context.

Pharmacology

PDE5 inhibitors

PDE5 inhibitors are the central pharmacological class for ED treatment. Sildenafil citrate (Viagra) was approved in the U.S. in 1998 and in Japan in 1999 as the world’s first oral ED-treatment drug. Vardenafil (Levitra, 2003) and tadalafil (Cialis, 2003) followed, establishing the current three-drug treatment landscape.

PDE5 inhibitors inhibit cGMP degradation in corpus-cavernosum smooth-muscle, enhancing erection-initiation-and-maintenance in response to sexual stimulation. They do not induce sexual stimulation directly but amplify the response to ongoing sexual stimulation. Tadalafil has a half-life of approximately 17.5 hours and a 36-hour effective duration, classifying it as a long-acting agent. Sildenafil and vardenafil have 4-5-hour half-lives, classifying them as short-acting agents.

Common adverse effects include headache, flushing, dyspepsia, and nasal congestion. Combination with nitrates (nitroglycerin, isosorbide) is absolutely contraindicated due to severe hypotension risk. Retinal disorders and cardiovascular disease require careful clinical assessment before prescription.

Other treatment options

For PDE5-inhibitor-non-responsive cases, alternatives include: (1) intracavernosal injection therapy (self-administered prostaglandin E1 injection); (2) vacuum erection device (negative-pressure-based mechanical assistance); (3) penile prosthesis implantation (surgical); and (4) testosterone replacement therapy (for LOH-syndrome-complicated cases). Low-intensity extracorporeal shock-wave therapy (Li-ESWT) is an emerging modality with continuing evaluation of long-term efficacy.

Cultural-historical context

Pre-modern representation

Erection has been embedded in religious-and-ritual representation across human cultures from antiquity. Ancient Greek Dionysian phallus-processions, the cult of Priapus (with the iconic erect-phallus deity image), and herm-pillar erections in classical-Greek civic statuary placed erection-imagery at the centre of festival-and-fertility culture. Roman wall-painting at Pompeii (preserved by the 79 CE Vesuvius eruption) includes commercial-entrance erect-phallus apotropaic-protection-and-prosperity charms throughout the city.

In Japan, the dōsojin (道祖神) road-side-deity cult, the konseijin (金精神, “metal-essence-deity”) fertility cult, and the broader phallic-worship tradition produced extensive wooden, stone, and votive-tablet erection-representations across pre-modern periods. The cults served as objects of fertility, illness-prevention, and marriage-bond petitionary worship. Edo-period shunga (erotic woodblock prints) used exaggerated-erection-imagery as a central compositional element, establishing the stylised-visual-language of erotic-scene depiction.

Modern taboo-formation

Modern medical-and-anatomical neutral description developed alongside the parallel-development of public-representation taboo. 19th-century Victorian sexual-abstinence norms and Meiji-Japanese public-decency regulation and obscenity-concept formation substantially restricted direct erection-imagery in public-representation contexts.

In Japan, Article 175 of the Penal Code (the obscenity-distribution provision) and the self-regulatory framework of film-and-content-rating organisations (Eirin, Content Soft Cooperative Association, and others) historically prohibited unmosaicked display of erect penises in commercial content distribution. The mosaic-processing (pixelisation) approach to symbolic concealment developed under this regulatory framework, with mosaicked erections becoming the standard commercial-distribution format and producing the distinctive viewer-completion visual-culture in which the audience completes the symbolic-outline mentally.

AV depiction

In adult-content production, erection is the physical substrate of sexual-excitement signalling. The male performer’s erection hardness, sustainability, and timing directly determine production-effect. On-set erection-management is correspondingly a core element of male-performer professional practice. The phenomenon of partial-loss-of-erection (nakaore) is a substantial production-efficiency concern, and PDE5 inhibitors and intracavernosal-injection therapy have on-set deployment, though with attendant health-risk awareness.

The opening-shot erection appearance functions across the production as the visual-confirmation marker of sexual-contact-imminence. Under the mosaic-regulation framework, framing-and-camera-work conventions and audio-design support the visual-signaling of erection presence even with the actual genitalia mosaic-concealed, producing the distinctive Japanese-AV visual-language.

In eromanga, doujinshi, and eroge, erection depiction operates through line-drawing, shading, and stylised symbol-conventions (sweat lines, steam, onomatopoeia such as “bikun”). Legal regulation of the underlying drawn imagery is more limited than for live-action depiction, but commercial self-regulation conventions (white-overlay, black-block, “muffling”) are typical.

Related Terms

• Penis (inkei)
• Penis (loanword)
• Glans (kitou)
• Foreskin condition (houkei)
• Partial loss of erection (nakaore)
• Morning erection (asa-dachi)
• Male menopause (LOH syndrome)
• Erectile dysfunction